A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5%

• Status: Completed
• Trial end date: 2017-08-18
• Target enrollment: 0
• Participant gender: All

Summary

A Multi-Center, Double-Blind, Randomized, Placebo controlled, Parallel-group study, comparing Ivermectin Lotion, 0.5%

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Taro Pharmaceuticals USA
• Treatments: Ivermectin

Criteria

Inclusion Criteria:

• Subjects 18 years of age or older must have provided IRB-approved written informed consent and sign a HIPAA authorization.

• Subjects must be willing and able to understand and comply with the requirements of the protocol, including attendance at the required study visits.

Exclusion Criteria:

• Subjects with a history of hypersensitivity or allergy to or any component of the study product.

• Subject with history of irritation or sensitivity to pediculicides or hair care products.